News from NORD

NORD Seeks Input Regarding Patient Protections and ACA


 

As the new administration and Congress consider replacing the Affordable Care Act with a new system, NORD is seeking input from patients and health care providers for its advocacy on behalf of rare disease patients. Patients or providers who have experiences or concerns to share regarding pre-existing conditions, annual or lifetime insurance caps, high-risk pools, or other topics may share their experiences with NORD.

Recommended Reading

January 13 Is Deadline for NORD Rare Impact Award Nominations
MDedge Endocrinology
Major Three-Year Study of Undiagnosed Diseases Announced
MDedge Endocrinology
New Guidelines Published for Diagnosis and Management of Cystathionine Beta-Synthase Deficiency
MDedge Endocrinology
PSC Partners Seeking a Cure Launches Campaign to Distinguish Between PSC and PBC
MDedge Endocrinology
Nominate a Patient or Colleague for a NORD Rare Impact Award
MDedge Endocrinology
Join Others Around the World in Observing Rare Disease Day
MDedge Endocrinology
AWaRDS Study Examines Services for Adults With Rare Disorders
MDedge Endocrinology
NORD Report Shows Majority of States Fall Short on Reducing Burden of Living With a Rare Disease
MDedge Endocrinology
IgG4-related disease can strike any organ system
MDedge Endocrinology
Rituximab is dramatically effective in IgG4-related disease
MDedge Endocrinology